← Leaderboards
Robert M. Cohen
University Of Cincinnati
$5,053,441
Attributed
$5,053,441
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $728.9K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,053,441 · 4
VA$0 · 1
By mechanism
R01$5,051,858 · 3
M01$1,583 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Cincinnati
Same institution · by research overlap
- Jason Heikenfeld$1,215,064
- Bryan Mackenzie$2,467,292
- Shahab A Akhter$2,557,241
- Fred Richard Beyette$4,726,267
- Evangelia G Kranias$18,880,856
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusBlood GlucoseErythrocytesComplications Of Diabetes MellitusHemoglobinCell AgeGlucoseHeterogeneityReproducibilityPreventMeasurementVariantGlycemic ControlMonitorGlycosylated Hemoglobin AGlucose MonitorCollaborationsLongevityComplementCost EffectiveBloodComplete Blood CountCostDevices
Grant awards (18)
Towards optimizing diabetes management and diagnosis by personalizing HbA1c targets$638,079
R01 · FY2024 · DK · contact PI
Towards optimizing diabetes management and diagnosis by personalizing HbA1c targets$679,533
R01 · FY2023 · DK · contact PI
Towards optimizing diabetes management and diagnosis by personalizing HbA1c targets$687,312
R01 · FY2022 · DK · contact PI
Towards optimizing diabetes management and diagnosis by personalizing HbA1c targets$701,895
R01 · FY2021 · DK · contact PI
Towards optimizing diabetes management and diagnosis by personalizing HbA1c targets$728,945
R01 · FY2020 · DK · contact PI
Does Variation in Mean Red Cell Age Impact HbA1c Interpretation?$0
I01 · FY2013 · VA · contact PI
Does Variation in Mean Red Cell Age Impact HbA1c Interpretation?$0
I01 · FY2012 · VA · contact PI
Does Variation in Mean Red Cell Age Impact HbA1c Interpretation?$0
I01 · FY2011 · VA · contact PI
Does Variation in Mean Red Cell Age Impact HbA1c Interpretation?$0
I01 · FY2009 · VA · contact PI
Endothelial progenitor cell biology in Type 1 diabetes$35,658
R01 · FY2008 · DK · contact PI
Endothelial progenitor cell biology in Type 1 diabetes$36,387
R01 · FY2007 · DK · contact PI
Endothelial progenitor cell biology in Type 1 diabetes$37,474
R01 · FY2006 · DK · contact PI
The Glycosylation Gap and Diabetic Complications$374,768
R01 · FY2005 · DK
Endothelial progenitor cell biology in Type 1 diabetes$38,375
R01 · FY2005 · DK
The Glycosylation Gap and Diabetic Complications$375,113
R01 · FY2004 · DK
Discordant Hemoglobin A1C$1,583
M01 · FY2004 · RR
The Glycosylation Gap and Diabetic Complications$380,835
R01 · FY2003 · DK
The Glycosylation Gap and Diabetic Complications$337,484
R01 · FY2002 · DK